Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 8:2021:7830136.
doi: 10.1155/2021/7830136. eCollection 2021.

Clinical Findings in Diabetes Mellitus Patients with COVID-19

Ting Guo  1   2   3 , Qinxue Shen  1   2   3 , Xiaoli Ouyang  1   2   3 , Wei Guo  1   2   3 , Jinhua Li  1   2   3 , Wenlong He  1   2   3 , Bo Yu  4 , Chenfang Wu  4 , Zhiguo Zhou  5 , Hong Luo  1   2   3 , Hong Peng  1   2   3
Affiliations

Clinical Findings in Diabetes Mellitus Patients with COVID-19

Ting Guo et al. J Diabetes Res. .

Abstract

Backgrounds: Diabetes mellitus (DM) is one of the most common comorbidities in patients with coronavirus disease (COVID-19). We aim to summarize the clinical features of DM patients with COVID-19 and find out potential factors associated with severe disease.

Methods: In this retrospective, single-center study, the medical records of patients with COVID-19 in Changsha, Hunan, China, from January 21, 2020, to February 19, 2020, were reviewed. Epidemiological information, clinical features, and outcomes were compared between DM patients admitted to the intensive care unit (ICU) or not.

Results: A total of 241 patients confirmed with COVID-19 were enrolled, including 19 DM patients. There were more patients in DM group admitted to the ICU than non-DM group (36.8% vs. 15.8%, P = 0.045). Compared with non-DM group in the ICU, there were more female patients from DM group in the ICU (85.7% vs. 31.4%, P = 0.024). On admission, the mean level of glycated hemoglobin A1c (HbA1c) was higher in the ICU DM patients than that in the non-ICU DM patients (8.5% vs. 7.1%). There were more DM patients with proteinuria in the ICU group than the non-ICU group (57.1% vs. 33.3%). Twelve DM patients (63.2%) changed diabetic therapy during hospitalization, and all DM patients admitted to the ICU used insulin. As of March 14, all 19 DM patients have been discharged, and no death occurred.

Conclusions: DM patients with COVID-19 are vulnerable to severe disease, especially for female patients. High levels of HbA1c and proteinuria could be potential risk factors for severe COVID-19 in DM patients. In addition to timely systemic therapy, the control of blood glucose and proper diabetic therapy is essential to improve the prognosis of severe DM patients with COVID-19.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest regarding the publication of this paper.

References

    1. Zhu N., Zhang D., Wang W., et al. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China. The New England Journal of Medicine. 2020;382(8):727–733. - PMC - PubMed
    1. World Health Organization (WHO) Coronavirous disease (COVID-19) pandemic. 2020, https://www.who.int/emergencies/diseases/novel-coronavirus-2019?gclid=Cj....
    1. WHO. General’s opening remarks at the Mission briefing on COVID-19. 2020, https://www.who.int/director-general/speeches/detail/who-director-genera....
    1. Guan W. J., Liang W. H., Zhao Y., et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journa. 2020;55(5):p. 2000547. doi: 10.1183/13993003.00547-2020. - DOI - PMC - PubMed
    1. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585. - DOI - PMC - PubMed

MeSH terms